Abstract
Obesity, a prevalent metabolic disorder characterized by excessive fat accumulation, can severely affect overall health if left untreated. This study investigated the potential of a 70% ethanol extract from Piper crocatum (red betel) leaves as an in vitro inhibitor of pancreatic lipase (PL), supported by computational analyses to identify alternative compounds to orlistat. The phytochemical profile was characterized using LC-MS/MS, revealing alkaloids and terpenoids with contents of 1.1 ± 0.01 mg CE/g and 3.14 ± 0.3 mg UAE/g, respectively. The extract exhibited 49 ± 9.1% inhibition of PL activity. Molecular docking identified three promising compounds: calanolide A (10.43 kcal/mol), myricanone (10.04 kcal/mol), and (-)-8-prenylnaringenin (9.49 kcal/mol). Based on DFT studies, these compounds showed favorable ADMET and electronic properties. MD simulations demonstrated that the PL-calanolide A complex maintained high conformational stability over 100 ns with a binding energy of 150.75 kJ/mol (MM-PBSA). These findings suggest that red betel leaf extract may serve as a promising natural pancreatic lipase inhibitor, as supported by robust in vitro and computational evidence supporting its potential for future anti-obesity drug development.
Recommended Citation
Gholam, Gusnia Meilin; Andrianto, Dimas; Septaningsih, Dewi Anggraini; and Safithri, Mega
(2025)
"Computational and In vitro Investigation of P. crocatum Bioactive Compounds as Pancreatic Lipase Inhibitors,"
Karbala International Journal of Modern Science: Vol. 11
:
Iss.
3
, Article 17.
Available at:
https://doi.org/10.33640/2405-609X.3423
Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Included in
Biology Commons, Chemistry Commons, Computer Sciences Commons, Physics Commons
